Skip to main content

DRW Securities, LLC

SEC CIK
0001481986
Latest filing
Aug 14, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by DRW Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
2,824
Value
$221.0K
% of portfolio
<0.1%
Quarters held
2
Since Q4 2025
Holdings of HALO by DRW Securities, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,824$221.0K<0.1%+2,824NewHolders
Q1 20260$00.0%−3,422−100.0%Sold outHolders
Q4 20253,422$230.3K<0.1%+3,422NewHolders